{"url":"https://lda.senate.gov/api/v1/filings/02e89e3a-b975-4026-b4e8-416a346b4e20/","filing_uuid":"02e89e3a-b975-4026-b4e8-416a346b4e20","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2018,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/02e89e3a-b975-4026-b4e8-416a346b4e20/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul Kim","dt_posted":"2018-10-25T11:40:51.993000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1717 K Street, N.W.","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":79610,"url":"https://lda.senate.gov/api/v1/registrants/79610/","house_registrant_id":32340,"name":"FOLEY HOAG LLP","description":"Law firm","address_1":"1717 K Street, N.W.","address_2":"Suite 1200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOSHUA ROSEN","contact_telephone":"+1 617-832-3120","dt_updated":"2026-06-26T11:26:51.819238-04:00"},"client":{"id":170729,"url":"https://lda.senate.gov/api/v1/clients/170729/","client_id":1004645,"name":"EDITAS MEDICINES, INC.","general_description":"Biotechnology Company","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"-Federal funding and regulation of innovative recombinant genetic technologies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":25904,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"KIM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23012,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"CAREY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}